September 18, 2014 10:35 PM ET

Pharmaceuticals

Company Overview of ViroPharma Inc.

Executive Profile

Vincent J. Milano

Director, Chairman of Compensation Committee and Member of Audit Committee, Vanda Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 4 different industries.

See Board Relationships
50$123,400

Background

Mr. Vincent J. Milano, also known as Vinnie, served as the Chief Executive Officer and President of ViroPharma Inc. from March 31, 2008 to January 24, 2014. Mr. Milano served as the Chief Operating Officer of ViroPharma Inc., from January 2006 to March 2008, Vice President from November 1997 to March 2008, Chief Financial Officer from November 1997 to October 2008, Treasurer from July 1996 to 2006 and Principal Accounting Officer until April 2008. Mr. Milano served as ...

Corporate Headquarters

730 Stockton Drive
Exton, Pennsylvania 19341

United States

Phone: 610-458-7300
Fax: 610-458-7380

Board Members Memberships

Director
Director
2003-Present
Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
2008-N/A
Former Chairman, Chief Executive Officer and President
2010-Present
Director, Chairman of Compensation Committee and Member of Audit Committee
2011-Present
Member of The Board of Directors
2014-Present
Director

Education

BS
Rider University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$84,582
Unexercisable Options$10,418
Total Number of Options$95,000

Total Compensation

Total Annual Cash Compensation$51,250
Total Calculated Compensation$123,400
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
$3.0M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
$3.0M
Masayo Tada Chief Executive Officer, President, Representative Director and Chairman of Risk Management Committee
Sumitomo Dainippon Pharma Co., Ltd.
--
Glenn A. Oclassen Sr.Chairman of the Board, Chief Executive Officer and President
Transcept Pharmaceuticals, Inc.
$560.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ViroPharma Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.